Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the clinical relevance of Lehmann TNBC subtypes by identifying any differences in response to neoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Santonja, Angela, Sánchez-Muñoz, Alfonso, Lluch, Ana, Chica-Parrado, Maria Rosario, Albanell, Joan, Chacón, José Ignacio, Antolín, Silvia, Jerez, José Manuel, de la Haba, Juan, de Luque, Vanessa, Fernández-De Sousa, Cristina Elisabeth, Vicioso, Luis, Plata, Yéssica, Ramírez-Tortosa, César Luis, Álvarez, Martina, Llácer, Casilda, Zarcos-Pedrinaci, Irene, Carrasco, Eva, Caballero, Rosalía, Martín, Miguel, Alba, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995183/
https://www.ncbi.nlm.nih.gov/pubmed/29899867
http://dx.doi.org/10.18632/oncotarget.25413

Ejemplares similares

Ejemplares similares